BIOFIRE SPOTFIRE PCR Laboratory Analyzer – Placement Agreement

The Biofire Spotfire PCR Laboratory Analyzer Placement Agreement aims to equip laboratory departments across Oklahoma Area Indian Health Services hospital and service unit locations with FDA-approved Biofire Spotfire CLIA-waived PCR analyzers to strengthen diagnostic testing capacity and elevate patient care for eligible Native American populations. These facilities are outpatient federal clinics providing ambulatory services, and uninterrupted operation of the analyzers is a critical requirement throughout the agreement term to ensure continuous, reliable testing. The solicitation, identified as 75H711-Q-0026, is issued under a Buy Indian Set-Aside, prioritizing Indian-owned businesses and aligning with the Department of Health and Human Services’ commitment to self-determination and economic opportunity for Native communities. The contract is classified under NAICS code 334516 for medical device manufacturing and is managed by the Administration Services Branch of the Department of Health and Human Services, with the primary point of contact being Krishna Harriman at the Oklahoma City office. Proposals must be submitted by July 31, 2026, and performance will be based at the designated location in Oklahoma City, Oklahoma.